Cantor Fitzgerald Weighs in on Teladoc Health FY2025 Earnings

Teladoc Health, Inc. (NYSE:TDOC) – Research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Teladoc Health in a research note issued on Thursday, February 27th. Cantor Fitzgerald analyst S. James forecasts that the health services provider will post earnings per share of ($0.78) for the year. The consensus estimate for Teladoc Health’s current full-year earnings is ($1.16) per share.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%.

TDOC has been the topic of a number of other research reports. Piper Sandler cut their price target on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. The Goldman Sachs Group cut their price target on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Monday. Royal Bank of Canada raised their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Oppenheimer cut their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $11.26.

Teladoc Health Price Performance

Shares of Teladoc Health stock opened at $9.21 on Monday. The firm has a market cap of $1.58 billion, a PE ratio of -1.60 and a beta of 1.05. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $15.95. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company’s fifty day simple moving average is $10.63 and its two-hundred day simple moving average is $9.61.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the business. Brucke Financial Inc. purchased a new position in Teladoc Health during the 4th quarter valued at about $92,000. Vise Technologies Inc. lifted its position in Teladoc Health by 4.9% during the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock valued at $274,000 after acquiring an additional 1,405 shares during the period. PharVision Advisers LLC purchased a new position in Teladoc Health during the 4th quarter valued at about $301,000. Twinbeech Capital LP lifted its position in Teladoc Health by 63.8% during the 4th quarter. Twinbeech Capital LP now owns 382,735 shares of the health services provider’s stock valued at $3,479,000 after acquiring an additional 149,118 shares during the period. Finally, Two Sigma Advisers LP lifted its position in Teladoc Health by 213.0% during the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock valued at $20,532,000 after acquiring an additional 1,537,094 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.